Department of Neurosurgery, Tel Aviv Medical Center, Israel.
Acta Neurochir (Wien). 2011 Sep;153(9):1727-35. doi: 10.1007/s00701-011-1061-y. Epub 2011 Jun 10.
Pregnant women with pathological conditions requiring a neurosurgical intervention pose a unique therapeutic challenge. Changes in normal physiology add to the complexity of patient management. We describe our experience in treating various neurosurgical diseases in parturient women.
Thirty-four pregnant and early postpartum women were treated at our center between 2003 and 2010. The general guideline used in these patients (now deserving re-evaluation based on the presented data) was to postpone surgery until the patient reached term (weeks 34-38 of gestation) unless there was evidence of a life- or function-threatening condition, in which case surgery was promptly performed.
Sixteen patients underwent neurosurgical intervention during pregnancy between 11 to 34 weeks of gestation (7 tumor, 3 vascular, 2 VP shunt, 2 spinal, 2 trauma). Thirteen women underwent a neurosurgical procedure after delivery (12 tumor, 1 spine), and 5 women were treated conservatively (2 vascular lesions, 3 trauma). Three patients underwent abortions (one spontaneous and two elective). The other 31 women delivered at 30-42 weeks' gestation. Of 12 patients whose definitive neurosurgical procedure was initially delayed, 5 were not able to complete their pregnancy naturally. Of 21 patients that underwent a cesarean section (CS), 3 were performed urgently. Although two pairs of twins and two singletons had an initial low Apgar score (<7), the outcome for all the neonates was good. Neurosurgical outcome was satisfactory.
Our experience demonstrates the safety of neurosurgical intervention and anesthesia during pregnancy. Delaying intervention often resulted in maternal deterioration and urgent intervention. Thus, pregnancy by itself should not be considered a major contraindication for performing a neurosurgical procedure, which should be considered early rather than late in most patients.
患有需要神经外科干预的病理状况的孕妇带来了独特的治疗挑战。正常生理变化增加了患者管理的复杂性。我们描述了我们在治疗产妇中各种神经外科疾病方面的经验。
2003 年至 2010 年期间,我们中心治疗了 34 名孕妇和产后早期妇女。这些患者使用的一般指导原则(现在根据提供的数据值得重新评估)是将手术推迟到患者达到足月(妊娠 34-38 周),除非有危及生命或功能的情况,在这种情况下,应立即进行手术。
16 名患者在妊娠 11 至 34 周期间接受了神经外科干预(7 例肿瘤,3 例血管病变,2 例 VP 分流术,2 例脊柱,2 例创伤)。13 名妇女在分娩后接受了神经外科手术(12 例肿瘤,1 例脊柱),5 名妇女接受了保守治疗(2 例血管病变,3 例创伤)。3 名患者流产(1 例自然流产,2 例人工流产)。其他 31 名妇女在 30-42 周时分娩。在 12 名最初延迟明确神经外科手术的患者中,有 5 名无法自然完成妊娠。21 名接受剖宫产(CS)的患者中,有 3 名紧急进行了 CS。尽管两对双胞胎和两个单胎最初的阿普加评分(<7)较低,但所有新生儿的结局都很好。神经外科结局令人满意。
我们的经验表明,神经外科干预和麻醉在怀孕期间是安全的。延迟干预通常会导致母体恶化和紧急干预。因此,怀孕本身不应被视为进行神经外科手术的主要禁忌症,大多数患者应尽早而不是晚期进行手术。